Verastem, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position
Verastem, Inc. (VSTM) had Debt Securities, Available-for-sale, Unrealized Loss Position of $6.00 million as of 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Notes › Investments › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2023-03-14
- 2022-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $6.00M.
- 2022-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $100.00K.
- 2022-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $100.00K.
- 2021-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $15.80M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2022-12-31 | $6.00M 10-K · filed 2023-03-14 |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-08 |
| 2021-12-31 | $15.80M 10-K · filed 2023-03-14 |
| 2021-09-30 | $9.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $11.00M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $13.40M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.00M 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.80M 10-K · filed 2021-03-18 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-30 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.10M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $46.90M 10-K · filed 2020-03-11 |
| 2018-09-30 | $18.30M 10-Q · filed 2018-11-07 |
| 2017-12-31 | $9.90M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |